CHRISTOPHER EDWIN JONES
Pilots at Trl Rd, Midland, MI
License number
Michigan A0963593
Issued Date
Mar 2016
Expiration Date
Mar 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
2401 N Trail Rd, Midland, MI 48642
Professional information
Manufacturing Engineer In Organofunctional Silanes At Dow Corning
Position:
Manufacturing Engineer in Organofunctional Silanes at Dow Corning
Location:
Saginaw, Michigan Area
Industry:
Higher Education
Work:
Dow Corning
- Midland, MI since Dec 2012
-
Manufacturing Engineer in Organofunctional Silanes
Dow Corning
Mar 2007 - Nov 2012
-
Manufacturing Engineer in Rubber Supply Chain
Dow Corning
Jun 2006 - Mar 2007
-
Process Design Engineer
Marathon Petroleum Company
May 2005 - Aug 2005
-
Chemical Engineering Intern
Education:
Michigan Technological University 2001 - 2006
BS, Chemical Engineering
BS, Chemical Engineering
Skills:
Chemical Engineering, Process Control, Six Sigma, Aspen, Aspen HYSYS, Design of Experiments, Process Simulation, Process Engineering
Dr. Christopher E Jones, Midland MI - DDS (Doctor of Dental Surgery)
Specialties:
Dentistry
Address:
6118 Merlin Ct, Midland 48640
(989) 835-5665 (Phone)
(989) 835-5665 (Phone)
Languages:
English
Education:
Medical School
Graduates of Institutions Not Listed As Medical Schools
Graduates of Institutions Not Listed As Medical Schools
Christopher Edwin Jones, Midland MI
Specialties:
Dentist
Address:
6118 Merlin Ct, Midland, MI 48640
Oral Drug Compliance Monitoring Using Magnetic-Field Sensors
US Patent:
2010032, Dec 23, 2010
Filed:
Apr 24, 2007
Appl. No.:
12/297321
Inventors:
Christopher M. Jones - Midland MI, US
Maysam Ghovanloo - Atlanta GA, US
Douglas P. White - Midland MI, US
Peter K. Mercure - Midland MI, US
Maysam Ghovanloo - Atlanta GA, US
Douglas P. White - Midland MI, US
Peter K. Mercure - Midland MI, US
Assignee:
DOW GLOBAL TECHNOLOGIES INC. - Midland MI
NORTH CAROLINA STATE UNIVERSITY - Raleigh NC
NORTH CAROLINA STATE UNIVERSITY - Raleigh NC
International Classification:
A61K 49/00, G01R 33/12, G01N 33/15
US Classification:
424 91, 324228
Abstract:
A method to measure compliance with a pharmaceutical regimen, by the steps of: (a) ingesting a dose of a medication () into the gastrointestinal tract of a person, the dose of medication () comprising a drug formulation () and a permanent magnet (); (b) as a result of the ingestion of step (a), detecting passage of the permanent magnet () past at least two magnetic field sensors () positioned apart from each other and adjacent to the gastrointestinal tract; and (c) measuring compliance with the pharmaceutical regimen by way of the detection of step (b). And, apparatus useful to measure compliance with a pharmaceutical regimen by detecting ingestion of a dose of medication () comprising a drug formulation () and a permanent magnet (), the apparatus including at least two magnetic field sensors () positioned apart from each other on a necklace (), each magnetic field sensor () being in electronic communication with a microprocessor for receiving signals from the magnetic field sensors () to determine the passage of a permanent magnet () between the magnetic field sensors ().
Method And System For Monitoring And Analyzing Compliance With Internal Dosing Regimen
US Patent:
2007023, Oct 11, 2007
Filed:
Mar 29, 2007
Appl. No.:
11/693404
Inventors:
Christopher Jones - Midland MI, US
Peter Mercure - Midland MI, US
Shakil Saghir - Midland MI, US
Peter Mercure - Midland MI, US
Shakil Saghir - Midland MI, US
International Classification:
A61K 49/00, G06Q 50/00
US Classification:
424009200, 424009600, 600300000, 705003000
Abstract:
A method and system for monitoring and analyzing compliance with an internal dosing regimen prescribed to be taken in multiple dose forms includes the steps of detecting internalization of a first dose form to generate a first data point, detecting internalization of a second dose form to generate a second data point, and analyzing the first data point and the second data point. The step of analyzing the first and second data points generates a metric of a variety of possible metric types. The first and second dose forms may be two of any plural number of sequentially-internalized dose forms which generate a like number of sequential data points. Subsequent internalizations of dose forms result in at least a like number of data points being generated. To effect the disclosed method a system is provided which includes at least two dose forms, a time stamp identifier operatively associated with each dose form, a receiving device for receiving the time stamp identifier data, and an analyzer for analyzing the received data,
Oral Drug Compliance Monitoring Using Radio Frequency Identification Tags
US Patent:
7382263, Jun 3, 2008
Filed:
May 18, 2006
Appl. No.:
11/436917
Inventors:
Kristine L. Danowski - Dallas TX, US
Larry S. Sun - Lake Jackson TX, US
Peter K. Mercure - Midland MI, US
Robert P. Haley - Midland MI, US
Douglas P. White - Lake Jackson TX, US
Michelle A. Pressler - Roscoe IL, US
Susan J. Babinec - Midland MI, US
Flor A. Castillo - Lake Jackson TX, US
Jahne Simon - Angleton TX, US
Paul E. Cranley - Lake Jackson TX, US
Diedre A. Strand - Midland MI, US
Bettina M. Rosner - San Diego CA, US
Robert B. Fletcher - Midland MI, US
Christopher M. Jones - Midland MI, US
Thomas H. Kalantar - Midland MI, US
Mark T. Bernius - Midland MI, US
W. Chris McDougall - Midland MI, US
Mark S. B. Felix - Uitikon Waldegg, CH
Larry S. Sun - Lake Jackson TX, US
Peter K. Mercure - Midland MI, US
Robert P. Haley - Midland MI, US
Douglas P. White - Lake Jackson TX, US
Michelle A. Pressler - Roscoe IL, US
Susan J. Babinec - Midland MI, US
Flor A. Castillo - Lake Jackson TX, US
Jahne Simon - Angleton TX, US
Paul E. Cranley - Lake Jackson TX, US
Diedre A. Strand - Midland MI, US
Bettina M. Rosner - San Diego CA, US
Robert B. Fletcher - Midland MI, US
Christopher M. Jones - Midland MI, US
Thomas H. Kalantar - Midland MI, US
Mark T. Bernius - Midland MI, US
W. Chris McDougall - Midland MI, US
Mark S. B. Felix - Uitikon Waldegg, CH
Assignee:
Dow Global Technologies Inc. - Midland MI
International Classification:
G08B 13/14, G08B 23/00, A61B 19/00, A61N 5/00
US Classification:
3405721, 3405727, 3405731, 128899, 6048901, 600 3, 600309
Abstract:
A device useful for oral drug delivery device consisting of: (a) a capsule, tablet or pill designed to disperse in the gastrointestinal system; (b) an RFID tag positioned in the capsule, tablet or pill, the RFID tag comprising an antenna; (c) an object selected from the group consisting of a magnet, a ferromagnetic object, a ferrite object and an electromagnetic shielding object positioned within, over or adjacent the antenna of the RFID tag to alter the antenna characteristics of the RFID tag so that if the RFID tag is interrogated before the capsule, tablet or pill disperses in the gastrointestinal system, the response of the RFID tag is sufficiently altered or attenuated to determine that the capsule, tablet or pill has not dispersed in the gastrointestinal system and so that if the RFID tag is interrogated after the capsule, tablet or pill has dispersed in the gastrointestinal system, the object separates from the RFID tag so that the response of the RFID tag is sufficiently detectable to determine that the capsule, tablet or pill has dispersed in the gastrointestinal system. Alternatively, a switch can be used to signal ingestion of the device, and change the response of the device.
Oral Drug Capsule Component Incorporating A Communication Device
US Patent:
2008017, Jul 24, 2008
Filed:
Jan 16, 2008
Appl. No.:
12/015201
Inventors:
Christopher Michael Jones - Midland MI, US
Douglas Paul White - Lake Jackson TX, US
Peter K. Mercure - Midland MI, US
Douglas Paul White - Lake Jackson TX, US
Peter K. Mercure - Midland MI, US
Assignee:
Dow Global Technologies, Inc. - Midland MI
International Classification:
A61K 9/52
US Classification:
424452
Abstract:
An improved upper capsule portion () of an oral drug delivery capsule () that includes an upper capsule portion () and a lower cup shaped capsule portion (), the lower cup shaped capsule portion () containing a medical formulation (), the lower capsule portion () being made of a material that disperses in gastrointestinal fluid, the lower capsule portion () having a mouth, the upper capsule portion () dimensioned to engage with the mouth of the lower capsule portion (). The improvement is the positioning of a communication device, such as an RFID tag (), on or integrally with the upper capsule portion () so that the communication device can communicate that the oral drug delivery capsule has been ingested. An alternate embodiment with an improved lower capsule portion is also disclosed.
Oral Drug Compliance Monitoring Using Sound Detection
US Patent:
2010013, Jun 3, 2010
Filed:
Jul 21, 2006
Appl. No.:
11/989225
Inventors:
Paul E. Cranley - Lake Jackson TX, US
Larry S. Sun - Lake Jackson TX, US
Malcolm W. Warren - Sandford MI, US
Michelle A. Pressler - Lake Jackson TX, US
Kristine L. Danowski - Midland MI, US
Hamed Lakrout - Midland MI, US
Christopher M. Jones - Midland MI, US
Doug P. White - Midland MI, US
Flor A. Castillo - Lake Jackson TX, US
Bettina M. Rosner - Aerzen, DE
Larry S. Sun - Lake Jackson TX, US
Malcolm W. Warren - Sandford MI, US
Michelle A. Pressler - Lake Jackson TX, US
Kristine L. Danowski - Midland MI, US
Hamed Lakrout - Midland MI, US
Christopher M. Jones - Midland MI, US
Doug P. White - Midland MI, US
Flor A. Castillo - Lake Jackson TX, US
Bettina M. Rosner - Aerzen, DE
International Classification:
A61K 49/00, A61P 43/00
US Classification:
424 91
Abstract:
A tablet, pill or capsule containing a material which produces sound waves when the tablet, pill or capsule is exposed to the gastrointestinal system. A two step method for oral drug compliance monitoring. The first step is to ingest a tablet, pill or capsule containing a material which produces sound waves when the tablet, pill or capsule is exposed to the gastrointestinal system of a person. The second step is to detect the sound waves produced when the tablet, pill or capsule is exposed to the gastrointestinal system to confirm that the person has ingested the tablet, pill or capsule.